Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801346 · ClinicalTrials.gov registry record
Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 224
- Enrollment target
NCT00801346 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 224 participants.
The verdict
NCT00801346 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 224 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about metabolic syndrome from young patients with acute lymphoblastic leukemia may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients with acute lymphoblastic leukemia in remission.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- PROCEDURE assessment of therapy complications
- PROCEDURE fatigue assessment and management
- OTHER metabolic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2008-11 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801346
The ClinicalTrials.gov registry entry for NCT00801346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00801346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00801346 about?
NCT00801346 is a clinical study titled "Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission". RATIONALE: Gathering information about metabolic syndrome from young patients with acute lymphoblastic leukemia may help doctors learn more about the disease. PURPOSE: This phase I trial is studying the metabolic syndrome in young patients with acute lymphoblastic leukemia in remission.
What is the current status of trial NCT00801346?
This trial is currently completed. The enrollment target is 224 participants. The study started on 2008-11. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00801346?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), assessment of therapy complications (PROCEDURE), fatigue assessment and management (PROCEDURE), metabolic assessment (OTHER).
Who is sponsoring clinical trial NCT00801346?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.